Physicians in fields like cardiology have traditionally looked to clinical practice guidelines to help articulate the best evidence-based care for patients. The rapidly growing movement to value-based care is prompting clinicians—including echocardiographers—to carefully weigh a more focused and integrative approach to delivering consistent, quality medicine: care pathways.

MyoKardia named pharmaceutical executive and physician David Meeker, MD, to its board of directors on April 18.

Adults in Denmark who were diagnosed with a first-time syncope had a 1.4-fold higher risk of occupational accidents and a two-fold higher risk of getting terminated from their job within two years when compared to the general employed population, according to a nationwide cohort study.

Deerfield Management agreed to provide Endologix, Inc. with up to $170 million in funding, including a $120 million, six-year secured term loan and a $50 million, three-year secured asset-based revolving line of credit.

The U.S. Food and Drug Administration (FDA) sent a warning letter to Abbott on April 12 alerting the company of violations at its manufacturing facility in Sylmar, California.

Between 1992 and 2014, the rate of malpractice claims paid on behalf of U.S. physicians declined 55.7 percent, while the mean compensation payment increased 23.3 percent.

A charity gala on April 8 raised more than $30,000 for local cardiac care services in West Virginia, The Parkersburg News and Sentinel reports.

Terumo Cardiovascular Group in Ann Arbor, Michigan, promoted Robert DeRyke to become the company’s CEO and president.